Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01339949

Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)

A Double-masked, Sham Controlled, Study to Evaluate the Safety and Effectiveness of Low Voltage Stereotactic Radiosurgery in Wet AMD Patients With Recurrent Leakage Secondary to CNV

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Oraya Therapeutics, Inc. · Industry
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to confirm the safety and to establish the effectiveness of low voltage external beam radiosurgery using the IRay System for the treatment of subjects with recurrent leakage secondary to neovascular Age-related Macular Degeneration (AMD) as determined by decreasing the number of Lucentis injections required during the first 12 months of the study.

Detailed description

The objective of this study is to confirm the safety and to establish the effectiveness of low voltage external beam radiosurgery using the IRay System for the treatment of subjects with recurrent leakage secondary to neovascular AMD as determined by decreasing the number of Lucentis injections required during the first 12 months of the study.

Conditions

Interventions

TypeNameDescription
DEVICEIRaylow voltage external beam radiosurgery
DEVICEIRaylow voltage external beam radiosurgery

Timeline

Start date
2011-06-01
Primary completion
2012-10-01
Completion
2014-10-01
First posted
2011-04-21
Last updated
2011-12-30

Locations

3 sites across 2 countries: Italy, United Kingdom

Source: ClinicalTrials.gov record NCT01339949. Inclusion in this directory is not an endorsement.